Merck (MRK) Other Gross PP&E Adjustments (2009 - 2025)

Merck (MRK) reported Other Gross PP&E Adjustments of -$1.2 billion for Q4 2025, down 11.57% year-over-year from -$1.3 billion in Q4 2024, and down 11.57% quarter-over-quarter from -$1.1 billion in Q4 2024.

Merck (MRK) Other Gross PP&E Adjustments (2009 - 2025) Analysis & Trends

Merck (MRK) has 17 years of Other Gross PP&E Adjustments data on file, last reported at -$1.2 billion in Q4 2025.

  • Other Gross PP&E Adjustments for Q4 2025 came in at -$1.2 billion, down 11.57% year-over-year; the trailing twelve-month figure through Dec 2025 was -$1.2 billion (down 11.57% YoY), and the FY2025 annual result was -$1.2 billion, down 11.57% from the prior year.
  • Other Gross PP&E Adjustments eased to -$1.2 billion in Q4 2025 per MRK's latest filing, from -$1.1 billion in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at -$1.1 billion in Q4 2022 and troughed at -$1.3 billion in Q4 2021.
  • A 5-year average of -$1.1 billion and a median of -$1.1 billion in 2023 frame the typical range for Other Gross PP&E Adjustments.
  • The sharpest annual moves came in 2022 and 2025: Other Gross PP&E Adjustments rose 16.59% in 2022, then fell 11.57% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$1.3 billion in 2021, then climbed by 16.59% to -$1.1 billion in 2022, then decreased by 5.71% to -$1.1 billion in 2023, then increased by 4.32% to -$1.1 billion in 2024, then slipped by 11.57% to -$1.2 billion in 2025.
  • Business Quant data shows MRK's Other Gross PP&E Adjustments at -$1.2 billion in Q4 2025, -$1.1 billion in Q4 2024, and -$1.1 billion in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn -941.03 Mn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn -
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn 49.60 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn -
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn -
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn -2.70 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn 8.42 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn -
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn -1.53 Bn
10 Novartis Ag 112.59 Bn 111.90 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.19 Bn
Dec 31, 2025 -1.19 Bn
Dec 31, 2024 -1.06 Bn
Dec 31, 2024 -1.06 Bn
Dec 31, 2023 -1.11 Bn
Dec 31, 2023 -1.11 Bn
Dec 31, 2022 -1.05 Bn
Dec 31, 2022 -1.05 Bn
Dec 31, 2021 -1.26 Bn
Dec 31, 2021 -1.26 Bn
Dec 31, 2020 -1.35 Bn
Dec 31, 2020 -1.35 Bn
Dec 31, 2019 -730.00 Mn
Dec 31, 2019 -730.00 Mn
Sep 30, 2019 -1.09 Bn
Sep 30, 2019 -1.09 Bn
Jun 30, 2019 -1.06 Bn
Jun 30, 2019 -1.06 Bn
Mar 31, 2019 -1.10 Bn
Mar 31, 2019 -1.10 Bn